Internal Medicine · Cleveland, OH
NPI
1912326646
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (216) 444-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
679 services
Medicare patients, 2024
296
Average age 69
Drug cost, 2024
$3.1M
3,840 prescriptions
Company payments, 2025
$5,837
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keren Zhou was code 99214 (office e&m - established), 167 times for 114 patients. In total Keren Zhou billed 679 services in 16 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 167 | 114 | $67.17 | $11K |
| 99214 Office E&M - Established | Office | 131 | 88 | $84.24 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 68 | 61 | $12.49 | $849 |
| 95251 Test - Miscellaneous | Facility | 65 | 40 | $23.62 | $1,535 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 53 | 45 | $12.02 | $637 |
| 99215 Office E&M - Established | Facility | 36 | 28 | $107.85 | $3,882 |
| 99204 Office E&M - New | Facility | 27 | 27 | $91.62 | $2,474 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 13 | $59.71 | $1,493 |
| 99204 Office E&M - New | Office | 20 | 20 | $100.73 | $2,015 |
| 99215 Office E&M - Established | Office | 19 | 13 | $125.18 | $2,378 |
| 76536 Ultrasound - Nonspecific | Facility | 14 | 14 | $19.85 | $278 |
| 99233 Hospital E&M - Subsequent | Facility | 13 | 13 | $86.08 | $1,119 |
By year: 2022 $22K for 335 services; 2023 $37K for 575 services; 2024 $42K for 679 services.
Medicare prescription drug claims, 2024
In 2024, the drug Keren Zhou prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 465 prescriptions and refills. In total Keren Zhou wrote 3,840 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 465 | 619 | 84 | $647K |
| Levothyroxine Sodium Generic | 420 | 1,149 | 122 | $4,290 |
| Ozempic Semaglutide | 247 | 382 | 59 | $357K |
| Metformin Hcl Er Metformin Hcl | 127 | 325 | 41 | $1,679 |
| Hydrocortisone Generic | 102 | 226 | 33 | $7,357 |
| Synthroid Levothyroxine Sodium | 99 | 285 | 32 | $6,281 |
| Metformin Hcl Generic | 98 | 273 | 34 | $2,450 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 97 | 248 | 46 | $15K |
| Jardiance Empagliflozin | 89 | 198 | 25 | $110K |
| Methimazole Generic | 70 | 151 | 17 | $443 |
| Trulicity Dulaglutide | 58 | 76 | 13 | $72K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 56 | 96 | 12 | $65K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 50 | 127 | 23 | $6,396 |
| Glipizide Er Glipizide | 48 | 136 | 15 | $661 |
| Atorvastatin Calcium Generic | 47 | 140 | 18 | $442 |
Brand drugs: 1,977 claims; generic drugs: 1,533 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keren Zhou $5,837 ($5,837 in general payments such as food, travel and fees) from 7 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $5,474.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.